Morphological and functional evidence against a sensory and sympathetic origin of nitric oxide synthase-containing nerves in the rat lower urinary tract.
To establish which type of nerves (parasympathetic, sympathetic or sensory) produce nitric oxide in the rat lower urinary tract, chemical denervation of primary afferents and sympathetic nerves was carried out by systemic treatment with capsaicin and 6-hydroxydopamine, respectively, followed by identification of neuronal nitric oxide synthase immunoreactivity. Functional in vitro studies were also performed to examine whether the synthesis and release of nitric oxide was affected following treatment with the respective neurotoxins. Nerve fibres immunoreactive for substance P and calcitonin gene-related peptide were found in control tissue, but could not be detected following capsaicin treatment. In comparison, nitric oxide synthase-immunoreactive fibres appeared to be unaffected by capsaicin treatment. Administration of 6-hydroxydopamine resulted in a complete disappearance of tyrosine hydroxylase-immunoreactive nerves, whereas nitric oxide synthase-containing nerve fibres did not appear to be affected by the treatment. In ultrastructural studies, nitric oxide synthase immunoreactivity, as studied by colloidal gold particles, was found in the axoplasm and not in association with intraneuronal structures or synaptic vesicles. Gold particles representing substance P immunoreactivity were seen as clusters associated with large granular vesicles. In consecutive sections of nerve fibres, substance P and nitric oxide synthase were not found in the same axon profile. In functional studies on urethral tissue, application of capsaicin (1 microM) produced a long-lasting relaxation. The nitric oxide synthase inhibitor NG-nitro-L-arginine (0.1 mM) had no effect on this response. Systemic treatment with capsaicin or 6-hydroxydopamine had no effect on nerve-evoked, nitric oxide-mediated relaxations. The data suggest that nitric oxide synthase-containing nerves in the rat lower urinary tract do not belong to nerve populations sensitive to either the sympathetic neurotoxin, 6-hydroxydopamine, or the sensory neurotoxin, capsaicin.
Persson
K
K
Department of Clinical Pharmacology, Lund University Hospital, Sweden.
Johansson
K
K
Alm
P
P
Larsson
B
B
Andersson
K E
KE
D000110:Acetylcholinesterase / Q000378:metabolism; D000818:Animals; D000918:Antibody Specificity; D001127:Arginine Vasopressin / Q000494:pharmacology; D015740:Calcitonin Gene-Related Peptide / Q000494:pharmacology; D002211:Capsaicin; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D017979:Gold Colloid; D008854:Microscopy, Electron; D008981:Molsidomine / Q000031:analogs & derivatives / Q000494:pharmacology; D009475:Neurons, Afferent / Q000737:chemistry / Q000201:enzymology* / Q000648:ultrastructure; D009478:Neuropeptide Y / Q000032:analysis / Q000276:immunology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D019335:Nitroarginine / Q000494:pharmacology; D016627:Oxidopamine; D051381:Rats; D017207:Rats, Sprague-Dawley; D013373:Substance P / Q000494:pharmacology; D013563:Sympathectomy, Chemical; D017779:Sympathetic Fibers, Postganglionic / Q000737:chemistry / Q000201:enzymology* / Q000648:ultrastructure; D013565:Sympatholytics; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis / Q000276:immunology; D014521:Urethra / Q000166:cytology / Q000294:innervation*; D019459:Urothelium / Q000294:innervation; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D004791:Enzyme Inhibitors; D017979:Gold Colloid; D009478:Neuropeptide Y; D013565:Sympatholytics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D001127:Arginine Vasopressin; D019335:Nitroarginine; D013373:Substance P; C002385:linsidomine; D016627:Oxidopamine; D008981:Molsidomine; D019001:Nitric Oxide Synthase; D014446:Tyrosine 3-Monooxygenase; D000110:Acetylcholinesterase; D015740:Calcitonin Gene-Related Peptide; D002211:Capsaicin